Long-term efficacy of Boswellia serrata in four patients with chronic cluster headache.

Abstract

BACKGROUND:

Cluster headache is an extremely severe and debilitating trigemino-autonomic pain syndrome. About 10% of patients with cluster headache manifest a chronic form (CCH).The present case series study aims to evaluate the long-term efficacy of Boswellia serrata (Sallaki H15) on headaches and disturbed sleep in patients with CCH.

CASE RESULTS:

In an open-label study, four patients with CCH and disturbed sleep received oral B. serrata.

CONCLUSION:

The results provide Class IV evidence that oral B. serrata reduces the intensity and frequency of headaches in patients with CCH.

• Authors: Christian Lampl, Bernhard Haider, Christine Schweiger
• Journal: Cephalalgia : an international journal of headache (Cephalalgia) Vol. 32 Issue 9 Pg. 719-22 (Jul 2012) ISSN: 1468-2982 [Electronic] England
• PMID: 22767962 (Publication Type: Case Reports, Journal Article)

Chemical References

• Resins, Plant
• Triterpenes
• salai guggal

Topics

• Administration, Oral
• Adult
• Aged
• Boswellia (chemistry)
• Cluster Headache (drug therapy)
• Female
• Follow-Up Studies
• Humans
• Male
• Middle Aged
• Resins, Plant (administration & dosage)
• Sleep Wake Disorders (drug therapy)
• Treatment Outcome
• Triterpenes (administration & dosage)